The serotonergic system: Its role in pathogenesis and early developmental treatment of autism

Current Neuropharmacology

Volumn 7, Issue 2, 2009, Pages 150-157

  Zafeiriou, D I ^a,b   Ververi, A ^a   Vargiami, E ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b NONE   (Greece)

Author keywords

5 hydroxytryptophan; Autism; Developmental intervention; Plasticity; Serotonergic; Serotonin

Indexed keywords

5 HYDROXYTRYPTOPHAN; AMINE OXIDASE (FLAVIN CONTAINING); BETA3 INTEGRIN; CARBIDOPA; NEUROTRANSMITTER; REELIN; SEROTONIN; SEROTONIN 1 RECEPTOR; SEROTONIN 2 RECEPTOR; SEROTONIN 3 RECEPTOR; SEROTONIN AGONIST; SEROTONIN RECEPTOR; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; TRYPTOPHAN HYDROXYLASE 2;

AUTISM; BRAIN DEVELOPMENT; DRUG ABSORPTION; DRUG EFFICACY; DRUG HALF LIFE; DRUG PENETRATION; DRUG SAFETY; DRUG TARGETING; EARLY INTERVENTION; EOSINOPHILIA MYALGIA SYNDROME; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GRIFFONIA; HUMAN; MEDICAL RESEARCH; NERVE CELL NETWORK; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NEUROIMAGING; NEUROPATHOLOGY; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; POSTNATAL DEVELOPMENT; PRENATAL DEVELOPMENT; PRENATAL DRUG EXPOSURE; PROTEIN DEFICIENCY; PROTEIN SYNTHESIS; RECEPTOR BINDING; REVIEW; SEROTONIN SYNDROME; SEROTONINERGIC SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUICIDAL BEHAVIOR; SYNAPSE; TIME TO MAXIMUM PLASMA CONCENTRATION; VARIABLE NUMBER OF TANDEM REPEAT;

EID: 70349690297     PISSN: 1570159X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157015909788848848     Document Type: Review

References (109)

1. American Psychiatric Association. (2000) Diagnostic and statistical manual of mental disorders, DSM-IV-TR. 4th ed. Washington, American Psychiatric Publishing.
2. Anderson, G.M. (2002) Genetics of childhood disorders: XLV. Autism, part 4: serotonin in autism. J. Am. Acad. Child. Adolesc. Psychiatry, 41, 1513-6.
3. Anderson, B.M., Schnetz-Boutaud, N.C., Bartlett, J., Wotawa, A.M., Wright, H.H., Abramson, R.K., Cuccaro, M.L., Gilbert, J.R., Pericak-Vance, M.A., Haines, J.L. (2009) Examination of association of genes in the serotonin system to autism. Neurogenetics., [Epub ahead of print].
4. Ansorge, M.S., Zhou, M., Lira, A., Hen, R., Gingrich, J.A. (2004) Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science, 306, 879-81.
5. Bailey, A., Luthert, P., Dean, A., Harding, B., Janota, I., Montgomery, M., Rutter, M., Lantos, P. (1998) A clinicopathological study of autism. Brain, 121, 889-905.
6. Balkovetz, D.F., Tiruppathi, C., Leibach, F.H., Mahesh, V.B., Ganapathy, V. (1989) Evidence for an imipramine-sensitive serotonin transporter in human placental brush-border membranes. J. Biol. Chem., 264, 2195-8.
7. Baumam, M.L., Kemper, T.L. (2005) Neuroanatomic observations of the brain in autism: a review and future directions. Int. J. Dev. Neurosci., 23, 183-7.
8. Beaulieu, J.M., Zhang, X., Rodriguiz, R.M., Sotnikova, T.D., Cools, M.J., Wetsel, W.C., Gainetdinov, R.R., Caron, M.G. (2008) Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiency. Proc. Natl. Acad. Sci. USA, 105, 1333-8.
9. Belik, J. (2008) Fetal and neonatal effects of maternal drug treatment for depression. Semin. Perinatol., 32, 350-4.
10. Bethea, T.C., Sikich, L. (2007) Early pharmacological treatment of autism: A rationale for developmental treatment. Biol. Psychiatry, 61, 521-37.
11. Birdsall, T.C. (1998) 5-Hydroxytryptophan: a clinically-effective precursor. Altern. Med. Rev., 3, 271-80.
12. Blue, M.E., Erzurumlu, R.S., Jhaveri, S. (1991) A comparison of pattern formation by thalamocortical and serotonergic afferents in the rat barrel field cortex. Cereb. Cortex., 1, 380-9.
13. Borue, X., Chenm J., Condron, B.G. (2007) Developmental affects ofSSRIs: lessons learned from animal studies. Int. J. Dev. Neurosci., 25, 341-7.
14. Boylan, C.B., Blue, M.E., Hohmann, C.F. (2007) Modeling early cortical serotonergic deficits in autism. Behav. Brain. Res., 176, 94-108.
15. Cadoret, R.J., Langbehn, D., Caspers, K., Troughton, E.P., Yucuis, R., Sandhu, H.K., Philibert, R. (2003) Associations of the serotonin transporter promoter polymorphism with aggressivity, attention deficit, and conduct disorder in an adoptee population. Compr. Psychiatry, 44, 88-101.
16. Calcagno, E., Canetta, A., Guzzetti, S., Cervo, L., Invernizzi, R.W. (2007) Strain differences in basal and post-citalopram extracellular 5-HT in the mouse medial prefrontal cortex and dorsal hippocampus: relation with tryptophan hydroxylase-2 activity. J. Neurochem., 103, 1111-20.
17. Casanova, M.F., Buxhoeveden, D.P., Switala, A.E., Roy, E. (2002) Minicolumnar pathology in autism. Neurology, 58, 428-432.
18. Casanova, M.F., Buxhoeveden, D., Gomez, J. (2003) Disruption in the inhibitory architecture of the cell minicolumn: implications for autism. Neuroscientist, 9, 496-507.
19. Cervo, L., Canetta, A., Calcagno, E., Burbassi, S., Sacchetti, G., Caccia, S., Fracasso, C., Albani, D., Forloni, G., Invernizzi, R.W. (2005) Genotype-dependent activity of tryptophan hydroxylase-2 determines the response to citalopram in a mouse model of depression. J. Neurosci., 25, 8165-72.
20. Chandana, S.R., Behen, M.E., Juhasz, C., Muzik, O., Rothermel, R.D., Mangner, T.J., Chakraborty, P.K., Chugani, H.T., Chugani, D.C. (2005) Significance of abnormalities in developmental trajectory and asymmetry of cortical serotonin synthesis in autism. Int. J. Dev. Neurosci., 23, 171-82.
21. Cho, I.H., Yoo, H.J., Park, M., Lee, Y.S., Kim, S.A. (2007) Family-based association study of 5-HTTLPR and the 5-HT2A receptor gene polymorphisms with autism spectrum disorder in Korean trios. Brain. Res., 1139, 34-41.
22. Choleris, E., Kavaliers, M., Pfaff, D.W. (2004) Functional genomics of social recognition. J. Neuroendocrinol., 16, 383-9.
23. Chugani, D.C., Muzik, O., Behen, M., Rothermel, R., Janisse, J.J., Lee, J., Chugani, H.T. (1999) Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Ann. Neurol., 45, 287-95.
24. Chugani, D.C. (2002) Role of altered brain serotonin mechanisms in autism. Mol. Psychiatry, 7, 16-7.
25. Cohen, I.L., Liu, X., Schutz, C., White, B.N., Jenkins, E.C., Brown, W.T., Holden, J.J. (2003) Association of autism severity with a monoamine oxidase A functional polymorphism. Clin. Genet., 64, 190-7.
26. Connell, S., Karikari, C., Hohmann, C.F. (2004) Sex-specific development of cortical monoamine levels in mouse. Brain. Res., 151, 187-91.
27. Cook, E.H. Jr., Charak, D.A., Arida, J., Spohn, J.A., Roizen, N.J., Leventhal, B.L. (1994) Depressive and obsessive-compulsive symptoms in hyperserotonemic parents of children with autistic disorder. Psychiatry Res., 52, 25-33
28. Cook, E.H. Jr., Courchesne, R., Lord, C., Cox, N.J., Yan, S., Lincoln, A., Haas, R., Courchesne, E., Leventhal, B.L. (1997) Evidence of linkage between the serotonin transporter and autistic disorder. Mol. Psychiatry, 2, 247-50.
29. Coon, H., Dunn, D., Lainhart, J., Miller, J., Hamil, C., Battaglia, A., Tancredi, R., Leppert, M.F., Weiss, R., McMahon, W. (2005) Possible association between autism and variants in the brain-expressed tryptophan hydroxylase gene (TPH2). Am. J. Med. Genet. B. Neuropsychiatr. Genet., 135, 42-6.
30. Coutinho, A.M., Sousa, I., Martins, M., Correia, C., Morgadinho, T., Bento, C., Marques, C., Ataide, A., Miguel, T.S., Moore, J.H., Oliveira, G., Vicente, A.M. (2007) Evidence for epistasis between SLC6A4 and ITGB3 in autism etiology and in the determination of platelet serotonin levels. Hum. Genet., 121, 243-56.
31. Croonenberghs, J., Verkerk, R., Scharpe, S., Deboutte, D., Maes, M. (2005) Serotonergic disturbances in autistic disorder: L-5-hydroxytryptophan administration to autistic youngsters increases the blood concentrations of serotonin in patients but not in controls. Life. Sci., 76, 2171-83.
32. Cross, S., Kim, S.J., Weiss, L.A., Delahanty, R.J., Sutcliffe, J.S., Leventhal, B.L., Cook, E.H.Jr., Veenstra-Vanderweele, J. (2008) Molecular genetics of the platelet serotonin system in first-degree relatives of patients with autism. Neuropsychopharmacology, 33, 353-60.
33. D'Eufemia, P., Finochiaro, R., Celli, M., Viozzi, L., Montelenone, D., Giardini, O. (1995) Low serum tryptophan to large neutral amino acids ratio in idiopathic infantile autism. Biomed. Pharmacother., 49, 288-92.
34. Daniels, J.L., Forssen, U., Hultman, C.M., Cnattingius, S., Savitz, D.A., Feychting, M., Sparen, P. (2008) Parental psychiatric disorders associated with autism spectrum disorders in the offspring. Pediatrics, 121, 1357-62.
35. Das, Y.T., Bagchi, M., Bagchi, D., Preuss, H.G. (2004) Safety of 5-hydroxy-tryptophan. Toxicol. Lett., 150, 111-22.
36. Davis, L.K., Hazlett, H.C., Librant, A.L., Nopoulos, P., Sheffield, V.C., Piven, J., Wassink, T.H. (2008) Cortical enlargement in autism is associated with a functional VNTR in the monoamine oxidase A gene. Am. J. Med. Genet. B. Neuropsychiatr. Genet., 147, 1145-51.
37. DeLong, G.R., Teague, L.A., McSwain Kamran, M. (1998) Effects of fluoxetine treatment in young children with idiopathic autism. Dev. Med. Child. Neurol., 40, 551-62.
38. Devlin, B., Cook, E.H. Jr., Coon, H., Dawson, G., Grigorenko, E.L., McMahon, W., Minshew, N., Pauls, D., Smith, M., Spence, M.A., Rodier, P.M., Stodgell, C., Schellenberg, G.D.; C.P.E.A. Genetics Network. (2005) Autism and the serotonin transporter: the long and short of it. Mol. Psychiatry, 10, 1110-6.
39. Dooley, A.E., Pappas, I.S., Parnavelas, J.G. (1997) Serotonin promotes the survival of cortical glutamatergic neurons in vitro. Exp. Neurol., 148, 205-14.
40. Fatemi, S.H., Stary, J.M., Egan, E.A. (2002) Reduced Blood Levels of Reelin as a Vulnerability Factor in Pathophysiology of Autistic Disorder. Cell. Mol. Neurobiol., 22, 139-52.
41. Fombonne, E. (2005) Epidemiology of autistic disorder and other pervasive developmental disorders. J. Clin. Psychiatry, 66, 3-8.
42. Fombonne, E. (2005) Epidemiological studies of pervasive developmental disorders. In: Volkmar, R.F., Paul, R., Klin, A., Cohen, D. Eds, Handbook of autism and pervasive developmental disorders. New Jersey, John Wiley & Sons. p. 45.
43. Goldberg, J., Anderson, G.M., Zwaigenbaum, L., Hall, G.B., Nahmias, C., Thompson, A., Szatmari, P. (2009) Cortical Serotonin Type-2 Receptor Density in Parents of Children with Autism Spectrum Disorders. J. Autism. Dev. Disord., 39, 97-104.
44. Gören, J.L. (2008) Antidepressants use in pediatric populations. Expert. Opin. Drug. Saf., 7, 223-5
45. Gustafsson, L. (2004) Comment on "Disruption in the inhibitory architecture of the cell minicolumn: implications for autism". Neuroscientist, 10, 189-91.
46. Haznedar, M.M., Buchsbaum, M.S., Wei, T.C., Hof, P.R., Cartwright, C., Bienstock, C.A., Hollander, E. (2000) Limbic circuitry in patients with autism spectrum disorders studied with positron emission tomography and magnetic resonance imaging. Am. J. Psychol., 157, 1994-2001.
47. Hohmann, C.F., Walker, E.M., Boylan, C.B., Blue, M.E. (2007) Neonatal serotonin depletion alters behavioral responses to spatial change and novelty. Brain. Res., 1139, 163-77.
48. Hollander, E., Novotny, S., Allen, A., Aronowitz, B., Cartwright, C., DeCaria, C. (2000) The relationship between repetitive behaviors and growth hormone response to sumatriptan challenge in adult autistic disorder. Neuropsychopharmacology, 22, 163-7.
49. Hollander, E., Phillips, A.T., Yeh, C.C. (2003) Targeted treatments for symptom domains in child and adolescent autism. Lancet, 362, 732-4.
50. Hollander, E., Phillips, A., Chaplin, W., Zagursky, K., Novotny, S., Wasserman, S., Iyengar, R. (2005) A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism. Neuropsychopharmacology, 30, 582-9.
51. Hranilović, D., Novak, R., Babié, M., Novokmet, M., Bujas-Petković, Z., Jernej, B. (2008) Hyperserotonemia in autism: the potential role of 5HT-related gene variants. Coll. Anthropol., 32, 75-80.
52. Huang, C.H., Santangelo, S.L. (2008) Autism and serotonin transporter gene polymorphisms: a systematic review and meta-analysis. Am. J. Med. Genet. B. Neuropsychiatr. Genet., 147B, 903-13.
53. Janusonis, S., Gluncic, V., Rakic, P. (2004) Early serotonergic projections to Cajal-Retzius cells: relevance for cortical development. J. Neurosci., 24, 1652-9.
54. Jones, M.B., Palmour, R.M., Zwaigenbaum, L., Szatmari, P. (2004) Modifier effects in autism at the MAO-A and DBH loci. Am. J. Med. Genet. B. Neuropsychiatr. Genet., 126, 58-65.
55. Kimmins, S., Lim, H.C., Parent, J., Fortier, M.A., MacLaren, L.A (2003) The effects of estrogen and progesterone on prostaglandins and integrin beta 3 (b3) subunit expression in primary cultures of bovine endometrial cells. Domest. Anim. Endocrinol., 25, 141-54.
56. Kocorowski, L.H., Helmstetter, F.J. (2001) Calcitonin gene-related peptide released within the amygdala is involved in Pavlovian auditory fear conditioning. Neurobiol. Learn. Mem., 75, 149-63.
57. Kolevzon, A., Mathewson, A.K., Hollander, E. (2006) Selective serotonin reuptake inhibitors in autism: A review of efficacy and tolerability. J. Clin. Psychiatry, 67, 407-14.
58. Kornstein, S.G., Schatzberg, A.F., Thase, M.E., Yonkers, K.A., McCullough, J.P., Keitner, G.I., Gelenberg, A.J., Davis, S.M., Harrison, W.M., Keller, M.B. (2000) Gender differences in treatment response to sertraline versus imipramine in chronic depression. Am. J. Psychiatry, 157, 1445-52.
59. Loveland, K.A., Bachevalier, J., Pearson, D.A., Lane, D.M. (2008) Fronto-limbic functioning in children and adolescents with and without autism. Neuropsychologia, 46, 49-62.
60. Magnussen, I., Nielsen-Kudsk, F. (1980) Bioavailability and related pharmacokinetics in man of orally administered L-5-hydroxytryptophan in a steady state. Acta Pharmacol. Toxicol., 46, 257-62.
61. Magnussen, I., Jensen, T.S., Rand, J.H., Van Woert, M.H. (1981) Plasma accumulation of metabolism of orally administered single dose L-5-hydroxytryptophan in man. Acta Pharmacol. Toxicol., 49, 184-9.
62. Magnussen, I., Van Woert, M.H. (1982) Human pharmacokinetics of long term 5-hydroxytryptophan combined with decarboxylase inhibitors. Eur. J. Clin. Pharmacol., 23, 81-6.
63. Makkonen, I., Riikonen, R., Kokki, H., Airaksinen, M.M., Kuikka, J.T. (2008) Serotonin and dopamine transporter binding in children with autism determined by SPECT. Dev. Med. Child. Neurol., 50, 593-7.
64. McDougle, J.C., Naylor, T.S., Cohen, J.D., Aghajanian, K.G., Heninger, R.G., Price, H.L. (1996) Effects of tryptophan depletion in drug-free adults with autistic disorder. Arch. Gen. Psychiatry, 53, 993-1000.
65. McNamara, I.M., Borella, A.W., Bialowas, L.A., Whitaker-Azmitia, P.M. (2008) Further studies in the developmental hyperserotonemia model (DHS) of autism: social, behavioral and peptide changes. Brain. Res., 1189, 203-14.
66. Meyer-Lindenberg, A., Buckholtz, J.W., Kolachana, B., Hariri, A.R., Pezawas, L., Blasi, G., Wabnitz, A., Honea, R., Verchinski, B., Callicott, J.H., Egan, M., Mattay, V., Weinberger, D.R. (2006) Neural mechanisms of genetic risk for impulsivity and violence in humans. Proc. Natl. Acad. Sci., 103, 6269-74.
67. Michelson, D., Page, S.W., Casey, R., Trucksess, M.W., Love, L.A., Milstien, S., Wilson, C., Massaquoi, S.G., Crofford, L.J., Hallett, M., Gold, P.W., Sternberg, E.M. (1994) An eosinophiliamyalgia syndrome related disorder associated with exposure to L-5-hydroxytryptophan. J. Rheumatol., 21, 2261-5.
68. Miquel, M.C., Kia, H.K., Boni, C., Doucet, E., Daval, G., Matthiessen, L., Hamon, M., Vergé, D. (1994) Postnatal development and localization of 5-HT1A receptor mRNA in rat forebrain and cerebellum. Dev. Brain. Res., 80, 149-57.
69. Molloy, C.A., Manning-Courtney, P. (2003) Prevalence of chronic gastrointestinal symptoms in children with autism and autistic spectrum disorders. Autism, 7, 165-71.
70. Mulder, E.J. (2006) The Hyperserotonemia of Autism Spectrum Disorders [dissertation]. The Netherlands, University of Rijks.
71. Murphy, D.G., Daly, E., Schmitz, N., Toal, F., Murphy, K., Curran, S., Erlandsson, K., Eersels, J., Kerwin, R., Ell, P., Travis, M. (2006) Cortical serotonin 5-HT2A receptor binding and social communication in adults with Aperger's syndrome: an in vivo SPECT study. Am. J. Psychiatry, 163, 934-6.
72. Murphy, D.L., Lerner, A., Rudnick, G., Lesch, K.P. (2004) Serotonin transporter: gene, genetic disorders and pharmacogenetics. Mol. Interv., 4, 109-23.
73. Nett-Clarke, C.A., Leslie, M.J., Lane, R.D., Rhoades, R.W. (1994) Effect of serotonin depletion on vibrissa-related patterns of thalamic afferents in the rat's somatosensory cortex. J. Neurosci., 14, 7594-607.
74. Nishikawa, S., Goto, S., Hamasaki, T., Kazumichi, Y., Ushio, Y. (2002) Involvement of reelin and Cajal-Retzius cells in the developmental formation of vertical columnar structures in the cerebral cortex: evidence from the study of mouse presubicular cortex. Cereb. Cortex., 12, 1024-30.
75. Orabona, G.M., Griesi-Oliveira, K., Vadasz, E., Bulcao, V.L., Takahashi, V.N., Moreira, E.S., Furia-Silva, M., Ros-Melo, A.M., Dourado, F., Matioli, R., Otto, P., Passos-Bueno, M.R. (2009) HTR1B and HTR2C in autism spectrum disorders in Brazilian families. Brain. Res., 1250, 14-9.
76. Osterheld-Haas, M.C., Hornung, J.P. (1996) Laminar development of the mouse barrel cortex: effects of neurotoxins against monoamines. Exp. Brain. Res., 110, 183-95.
77. Pardo, C.A., Eberhart, C.G. (2007) The Neurobiology of Autism. Brain. Pathol., 17, 434-47.
78. Pecins-Thompson, M., Brown, N.A., Bethea, C.L. (1998) Regulation of serotonin re-uptake transporter mRNA expression by ovarian steroids in Rhesus macaques. Brain Res. Mol. Brain Res., 53, 120-9.
79. Persico, A.M., Altamura, C., Calia, E., Puglisi-Allegra, S., Ventura, R., Lucchese, F., Keller, F. (2000) Serotonin depletion and barrel cortex development: impact of growth impairment vs. serotonin effects on thalamocortical endings. Cereb. Cortex., 10, 181-91.
80. Prasad, H.C., Steiner, J.A., Sutcliffe, J.S., Blakely, R.D. (2009) Enhanced activity of human serotonin transporter variants associated with autism. Philos. Trans. R. Soc. Lond. B. Biol. Sci., 364, 163-73.
81. Ramoz, N., Cai, G., Reichert, J.G., Corwin, T.E., Kryzak, L.A., Smith, C.J., Silverman, J.M., Hollander, E., Buxbaum, J.D. (2006) Family-based association study of TPH1 and TPH2 polymorphisms in autism. Am. J. Med. Genet. B. Neuropsychiatr. Genet., 141B, 861-7.
82. Ramoz, N., Reichert, J.G., Corwin, T.E., Smith, C.J., Silverman, J.M., Hollander, E., Buxbaum, J.D. (2006) Lack of evidence for association of the serotonin transporter gene SLC6A4 with autism. Biol. Psychiatry, 60, 186-91.
83. Sacco, R., Papaleo, V., Hager, J., Rousseau, F., Moessner, R., Militerni, R., Bravaccio, C., Trillo, S., Schneider, C., Melmed, R., Elia, M., Curatolo, P., Manzi, B., Pascucci, T., Puglisi-Allegra, S., Reichelt, K.L., Persico, A.M. (2007) Case-control and family-based association studies of candidate genes in autistic disorder and its endophenotypes: TPH2 and GLO1. B.M.C. Med. Genet., 8, 11.
84. Saintier, D., Burde, M.A., Rey, J.M., Maudelonde, T., de Vernejoul, M.C., Cohen-Solal, M.E. (2004) 17b-estradiol downregulates b3-integrin expression in differentiating and mature human osteoclasts. J. Cell. Physiol., 198, 269-76.
85. Schultz, R.T. (2005) Developmental deficits in social perception in autism: the role of the amygdala and fusiform face area. Int. J. Dev. Neurosci., 23, 125-41.
86. Serretti, A., Calati, R., Mandelli, L., De Ronchi, D. (2006) Serotonin transporter gene variants and behavior: a comprehensive review. Curr. Drug. Targets, 7, 1659-69.
87. Sikich, L., Hickok, J.M., Todd, R.D. (1990) 5-HT1A receptors control neurite branching during development. Brain Res. Dev. Brain Res., 56, 269-74.
88. Silva, H., Nieto, R., Montes, C., Paredes, A., Rentería, P., Ramírez, A., Jerez, S. (2008) Gender-related differences in functional assessment of serotonergic system in healthy young subjects. Actas. Esp. Psiquiatr., 36, 218-22.
89. Sodhi, M.S., Sanders-Bush, E. (2004) Serotonin and brain development. Int. Rev. Neurobiol., 59, 111-74.
90. Stanfield, A.C., McIntosh, A.M., Spencer, M.D., Philip, R., Gaur, S., Lawrie, S.M. (2008) Towards a neuroanatomy of autism: a systematic review and meta-analysis of structural magnetic resonance imaging studies. Eur. Psychiatry, 23, 289-99.
91. Sugie, Y., Sugie, H., Fukuda, T., Ito, M., Sasada, Y., Nakabayashi, M., Fukashiro, K., Ohzeki, T. (2005) Clinical efficacy of fluvoxamine and functional polymorphism in a serotonin transporter gene on childhood autism. J. Autism. Dev. Disord., 35, 377-85.
92. Sundstrom, E., Kolare, S., Souverbie, F., Samuelsson, E.B., Pschera, H., Lunell, N.O., Seiger, A. (1993) Neurochemical differentiation of human bulbospinal monoaminergic neurons during the first trimester. Brain. Res. Dev. Brain. Res., 75, 1-12.
93. Sutcliffe, J.S., Delahanty, R.J., Prasad, H.C., McCauley, J.L., Han, Q., Jiang, L., Li, C., Folstein, S.E., Blakely, R.D. (2005) Allelic heterogeneity at the serotonin transporter locus (SLC6A4) confers susceptibility to autism and rigid-compulsive behaviors. Am. J. Hum. Genet., 77, 265-79.
94. Tecott, L.H., Logue, S.F., Wehner, J.M., Kauer, J.A. (1998) Perturbed dentate gyrus function in serotonin 5-HT2C receptor mutant mice. Proc. Natl. Acad. Sci. USA, 95, 15026-31.
95. Turner, E.H., Loftis, J.M., Blackwell, A.D. (2006) Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan. Pharmacol. Ther., 109, 325-38.
96. Vaidya, V.A., Marek, G.J., Aghajanian, G.K., Duman, R.S. (1997) 5-HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex. J. Neurosci., 17, 2785-95.
97. Veenstra-Vander Weele, J., Kim, S.J., Lord, C., Courchesne, R., Akshoomoff, N., Leventhal, B.L., Courchesne, E., Cook, E.H. Jr. (2002) Transmission disequilibrium studies of the serotonin 5-HT2A receptor gene (HTR2A) in autism. Am. J. Med. Genet., 114, 277-83.
98. Wassink, T.H., Hazlett, H.C., Epping, E.A., Arndt, S., Dager, S.R., Schellenberg, G.D., Dawson, G., Piven, J. (2007) Cerebral cortical gray matter overgrowth and functional variation of the serotonin transporter gene in autism. Arch. Gen. Psychiatry, 64, 709-17.
99. Weiss, L.A., Abney, M., Cook, E.H.Jr., Ober, C. (2005) Sex-specific genetic architecture of whole blood serotonin levels. Am. J. Hum. Genet., 76, 33-41.
100. Weiss, L.A., Kosova, G., Delahanty, R.J., Jiang, L., Cook, E.H., Ober, C., Sutcliffe, J.S. (2006) Variation in ITGB3 is associated with whole-blood serotonin level and autism susceptibility. Eur. J. Hum. Genet., 14, 923-31.
101. Weiss, L.A., Ober, C., Cook, E.H. Jr. (2006) ITGB3 shows genetic and expression interaction with SLC6A4. Hum. Genet., 120, 93-100.
102. Westenberg, H.G., Gerritsen, T.W., Meijer, B.A., van Praag, H.M. (1982) Kinetics of 1-5 hydroxytryptophan in healthy subjects. Psychiatry. Res., 7, 373-85.
103. Whitaker-Azmitia, P.M. (2001) Serotonin and brain development: role in human developmental diseases. Brain. Res. Bull., 56, 479-85.
104. Whitaker-Azmitia, P.M. (2005) Behavioral and cellular consequences of increasing serotonergic activity during brain development: A role in autism? Int. J. Dev. Neurosci., 23, 75-83.
105. Wing, L., Gould, J. (1979) Severe impairments of social interaction and associated abnormalities in children: epidemiology and classification. J. Autism. Dev. Disord., 9, 11-29.
106. World Health Organization. (1992) International Classification of Mental and Behavioral Disorders, Diagnostic Criteria for Research, 10th ed. Geneva, WHO.
107. Xu, Y., Sari, Y., Zhou, F.C. (2004) Selective serotonin reuptake inhibitor disrupts organization of thalamocortical somatosensory barrels during development. Dev. Brain. Res., 150, 151-61.
108. Yan, W., Wilson, C.C., Haring, J.H. Effects of neonatal serotonin depletion on the development of rat dentate granule cells. (1997) Brain. Res. Dev. Brain. Res., 98, 177-84.
109. Yoo, H.J., Lee, S.K., Park, M., Cho, I.H., Hyun, S.H., Lee, J.C., Yang, S.Y., Kim, S.A. (2009) Family- and population-based association studies of monoamine oxidase A and autism spectrum disorders in Korean. Neurosci. Res., 63, 172-6.